Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of DIPNA PHARMACHEM. For more details, see the DIPNA PHARMACHEM quarterly results and DIPNA PHARMACHEM share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.2 |
No. of shares | m | 24.05 |
1 Week | % | -6.6 |
1 Month | % | -14.1 |
1 Year | % | -35.1 |
52 week H/L | Rs | 24.1/8.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DIPNA PHARMACHEM EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | 34 | |
Low | Rs | NA | NA | NA | NA | 11 | |
Sales per share (Unadj.) | Rs | 5,045.5 | 7,634.8 | 7,750.0 | 18,188.8 | 83.5 | |
Earnings per share (Unadj.) | Rs | 8.0 | 14.8 | 6.0 | 291.8 | 0.8 | |
Diluted earnings per share | Rs | 0.0 | 0.0 | 0.0 | 0.5 | 0.4 | |
Cash flow per share (Unadj.) | Rs | 10.3 | 17.0 | 7.8 | 293.3 | 0.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 122.0 | 137.0 | 143.0 | 434.8 | 20.3 | |
Adj. book value per share | Rs | 0.2 | 0.2 | 0.2 | 0.7 | 10.1 | |
Shares outstanding (eoy) | m | 0.04 | 0.04 | 0.04 | 0.04 | 11.97 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0 | 0.3 | |
Avg P/E ratio | x | 0 | 0 | 0 | 0 | 28.9 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | 28.6 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | 1.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | 264 | |
Total wages/salary | Rs m | 4 | 4 | 4 | 6 | 5 |
DIPNA PHARMACHEM INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 202 | 305 | 310 | 728 | 999 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total revenues | Rs m | 202 | 305 | 310 | 728 | 999 | |
Gross profit | Rs m | 5 | 4 | 4 | 23 | 25 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 4 | 4 | 4 | 7 | 11 | |
Profit before tax | Rs m | 1 | 1 | 1 | 16 | 14 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 4 | 5 | |
Profit after tax | Rs m | 0 | 1 | 0 | 12 | 9 | |
Gross profit margin | % | 2.4 | 1.5 | 1.3 | 3.1 | 2.5 | |
Effective tax rate | % | 42.0 | 1.5 | 56.0 | 25.9 | 34.0 | |
Net profit margin | % | 0.2 | 0.2 | 0.1 | 1.6 | 0.9 |
DIPNA PHARMACHEM BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 140 | 184 | 248 | 362 | 775 | |
Current liabilities | Rs m | 136 | 145 | 205 | 287 | 390 | |
Net working cap to sales | % | 2.2 | 12.7 | 13.6 | 10.3 | 38.5 | |
Current ratio | x | 1.0 | 1.3 | 1.2 | 1.3 | 2.0 | |
Inventory Days | Days | 0 | 0 | 0 | 0 | 0 | |
Debtors Days | Days | 160,026,095 | 1,339 | 1,760 | 135,328,193 | 104,217,013 | |
Net fixed assets | Rs m | 1 | 0 | 0 | 0 | 0 | |
Share capital | Rs m | 0 | 0 | 0 | 0 | 120 | |
"Free" reserves | Rs m | 5 | 5 | 5 | 17 | 124 | |
Net worth | Rs m | 5 | 5 | 6 | 17 | 244 | |
Long term debt | Rs m | 0 | 34 | 37 | 58 | 142 | |
Total assets | Rs m | 141 | 184 | 248 | 362 | 776 | |
Interest coverage | x | 1.1 | 1.2 | 1.2 | 3.3 | 2.2 | |
Debt to equity ratio | x | 0 | 6.1 | 6.4 | 3.3 | 0.6 | |
Sales to assets ratio | x | 1.4 | 1.7 | 1.3 | 2.0 | 1.3 | |
Return on assets | % | 3.3 | 2.4 | 1.5 | 5.1 | 2.6 | |
Return on equity | % | 6.6 | 10.8 | 4.2 | 67.1 | 3.7 | |
Return on capital | % | 98.6 | 11.5 | 9.6 | 30.0 | 6.5 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
DIPNA PHARMACHEM CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 0 | -31 | -24 | 28 | -210 | |
From Investments | Rs m | 0 | 0 | 0 | -0 | -0 | |
From Financial Activity | Rs m | 0 | 32 | 25 | -28 | 265 | |
Net Cashflow | Rs m | 0 | 1 | 1 | -0 | 55 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Keyur Shah | COMP SEC: Khushboo Jethaliya | YEAR OF INC: 2011 | BSE CODE: 543594 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare DIPNA PHARMACHEM With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.